Neoadjuvant chemotherapy with epirubicin-vinorelbine and G-CSF in locoregionally advanced breast cancer: Our experience

被引：0
|
作者：
Savarino, A. [1 ]
Fabiano, E. [1 ]
Maniaci, V [1 ]
Puliafito, I [1 ]
Sauta, M. G. [1 ]
Bene, A. [1 ]
机构：
[1] Univ Messina, Human Pathol Dept, Med Oncol & Innovat Therapies Unit, I-98100 Messina, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant chemotherapy with high dose epirubicin (HDEPI), vinorelbine (VNR) and cisplatin (CP) plus G-CSF, in inoperable stage IIIAN2-IIIB non small cell lung cancer (NSCLC)
    Guaraldi, M
    Mclotti, B
    Piana, E
    Oliverio, G
    Marino, A
    Ravaioli, A
    Martoni, A
    ANNALS OF ONCOLOGY, 2000, 11 : 5 - 5
  • [32] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Garcia-Mata, Jesus
    Garcia-Palomo, Andres
    Calvo, Lourdes
    Mel, Ramon
    Cruz, Juan Jesus
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (11): : 739 - 744
  • [33] Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
    Jesús García-Mata
    Andrés García-Palomo
    Lourdes Calvo
    Ramón Mel
    Juan Jesús Cruz
    Manuel Ramos
    Clinical and Translational Oncology, 2008, 10 : 739 - 744
  • [34] Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis
    Li, Xiang
    Zheng, Huan
    Yu, Man-Cheng
    Wang, Wei
    Wu, Xin-Hong
    Yang, Dong-Mei
    Xu, Juan
    SUPPORTIVE CARE IN CANCER, 2020, 28 (11) : 5085 - 5097
  • [35] Phase III Randomized Trial of Dose Intensive Neoadjuvant Chemotherapy with or Without G-CSF in Locally Advanced Breast Cancer: Long-Term Results
    Arun, Banu K.
    Dhinghra, Kapil
    Valero, Vicente
    Kau, Shu-Wan
    Broglio, Kristine
    Booser, Daniel
    Guerra, Laura
    Yin, Guosheng
    Walters, Ronald
    Sahin, Aysegul
    Ibrahim, Nuhad
    Buzdar, Aman U.
    Frye, Debbie
    Sneige, Nour
    Strom, Eric
    Ross, Merrick
    Theriault, Richard L.
    Vadhan-Raj, Saroj
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2011, 16 (11): : 1527 - 1534
  • [36] Effectiveness and resulting surgical behavior after neoadjuvant chemotherapy in locally advanced breast cancer: our experience
    Rossi, G.
    Martellucci, I.
    Marsili, S.
    Senologico, G. O. M.
    Francini, G.
    Neri, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 21 - 21
  • [37] Primary chemotherapy, MMM and FEC 50 intensified by G-CSF in elderly patients with locally advanced breast cancer
    Ionta, MT
    Nicolosi, MP
    Mascia, MG
    Murru, R
    Massidda, B
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 89
  • [38] Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?
    Hupperets, P. S.
    Tjan-Heijnen, V. C.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1181 - 1183
  • [39] Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer
    Ejlertsen, B
    Mouridsen, H
    Langkjer, ST
    Andersen, J
    Sjostrom, J
    Kjaer, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S67
  • [40] A phase II study of epirubicin, vinorelbine and cisplatin in advanced breast cancer
    Garrone, O
    Principe, E
    Occelli, M
    Mercuri, M
    Numico, G
    Granetto, C
    Di Costanzo, G
    Rattazzi, PD
    Merlano, M
    ANTI-CANCER DRUGS, 2004, 15 (01) : 23 - 27
12345